Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.
CITATION STYLE
Weaver, A., Rubinstein, S., & Cornell, R. F. (2020, May 19). Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2020.00815
Mendeley helps you to discover research relevant for your work.